American Methadone Treatment Association1
Opioid Treatment in the 21st Century: Implementing the Vision
October 7-10, 2001
St. Louis

Advocacy Events and Patient Participation
NAMA at AMTA Conference 2001
Sunday, October 7th
Pre-conference Meeting 9 A.M. to 5 P.M.
Unifying the Treatment Community
Moderator Todd Rosendale, Center for Substance Abuse Treatment
Speakers
- Fred Christie, AFFIRM (President)
- Jo Sotheran, NAMA Board of Directors (Treasurer)
- James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
- Joycelyn Woods, NAMA Board of Directors (President)
(Sponsored by the Center for Substance Abuse Treatment)
The First Patients Advocates Illumination Award 4 P.M.
Chair Todd Rosendale, Center for Substance Abuse Treatment
Presented by Joycelyn Woods, NAMA
The Advocacy Coalition will present the first patient’s Advocates Illumination Award to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment.
Presented to Dr. Marc Shinderman and the Center for Addiction Problems
(Sponsored by the Center for Substance Abuse Treatment)
Welcome Reception 6 P.M. (Conference Starts)
Monday, October 8th
Opening Address 8 A.M.
Policy Makers Luncheon 11 A.M. to 1 P.M.
Chair Mark Parrino, American Methadone Treatment Association
The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and organizational representatives (i.e. ASAM, NAMA). The luncheon was initiated as a way to get the regulatory bodies together for discussions prior to changes in the federal regulation.
(Sponsored by the American Methadone Treatment Association)
Poster Session 2 P.M 2
Hepatitis C and the Methadone Patient
Authors
- Tony Scro, NAMA Board of Directors (Grievance Coordinator) and ABATE (President)
- Rokki Baker, NAMA Board of Directors (Chapter Coordinator), NAMA Nor-Cal (President) and Santa Cruz Hepatitis C Task Force
- John Finger, NAMA (Regional Director), TexNAMA (President)
- Barbara Finger, NAMA Board of Directors (Communication’s Specialist),TexNAMA (Vice President)
NAMA Organizational Meeting 7 P.M.
Chairs
Jo Sotheran, NAMA Board of Directors (Treasurer)
Joycelyn Woods, NAMA Board of Directors (President)
Many organizations use the conference as an opportunity to meet and NAMA is no different. Twenty-six NAMA representatives from around the country met to discuss patient advocacy issues.
Tuesday, October 9th
Hot Topic Round Table 2 P.M.
Administrative Detox: Necessary Use or Abuse
Authors
- Joe Neuberger, Delaware NAMA (President)
- James DePasquale, NAMA Membership Director and Long Beach Patient Comittee
The first conference of the new millennium heralds the recognition and acceptance of patient advocacy. For the first time no less than three awards were presented to patient advocates recognizing their work. |
![]() |
Wednesday, October 10th
Workshop 8 A.M.
Past, Present and Future: A Selection of Unfinished Business in Methadone Treatment
Authors
- Moderator, Howard Lotsof, NAMA Acting Membership Director
- Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President)
- Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President)
- Jo Sotheran, NAMA Board of Directors (Treasurer)
- James DePasquale, NAMA Membership Director and Long Beach Patient Committee
- Joycelyn Woods, NAMA Board of Directors (President)
Press Conference 12 P.M.
Director Jeanne Henry, Office of Public Affairs, Sate of Missouri, Department of Mental Health
Patient Advocacy Interviews Organized by Norma Alexander, NAMA Media Director
Interviews
- Joycelyn Woods, NAMA Board of Directors (President)
- Howard Lotsof, NAMA Acting Membership Director
- Barbara Finger, NAMA Board of Directors (Communication’s Specialist) and TexNAMA (Vice President)
Sponsored by State of Missouri, Department of Mental Health
Closing Address 12 P.M.
Smoozing Around The Conference
A quick photo album of the conference.
Notes
1. Now the American Association for the Treatment of Opioid Dependence.
2. The Hepatitis C Poster Session is only available as a PowerPoint Presentation!